Analysis of FUS , PFN2, TDP-43 , and PLS3 as potential disease severity modifiers in spinal muscular atrophy.

MLA

Wadman, Renske I., et al. “Analysis of FUS , PFN2, TDP-43 , and PLS3 as Potential Disease Severity Modifiers in Spinal Muscular Atrophy.” Neurology. Genetics, vol. 6, no. 1, Jan. 2019, p. e386. EBSCOhost, https://doi.org/10.1212/NXG.0000000000000386.

APA

Wadman, R. I., Jansen, M. D., Curial, C. A. D., Groen, E. J. N., Stam, M., Wijngaarde, C. A., Medic, J., Sodaar, P., van Eijk, K. R., Huibers, M. M. H., van Kuik, J., Lemmink, H. H., van Rheenen, W., Veldink, J. H., van den Berg, L. H., & van der Pol, W. L. (2019). Analysis of FUS , PFN2, TDP-43 , and PLS3 as potential disease severity modifiers in spinal muscular atrophy. Neurology. Genetics, 6(1), e386. https://doi.org/10.1212/NXG.0000000000000386

Chicago

Wadman, Renske I, Marc D Jansen, Chantall A D Curial, Ewout J N Groen, Marloes Stam, Camiel A Wijngaarde, Jelena Medic, et al. 2019. “Analysis of FUS , PFN2, TDP-43 , and PLS3 as Potential Disease Severity Modifiers in Spinal Muscular Atrophy.” Neurology. Genetics 6 (1): e386. doi:10.1212/NXG.0000000000000386.